Pharmacological modulation of fibrinolytic response - In vivo and in vitro studies

Pharmacological Reports : PR
Karol KramkowskiW Buczko

Abstract

Fibrinolysis is an action of converting plasminogen by its activators, like tissue- or urokinase-type plasminogen activators (t-PA, u-PA), to plasmin, which in turn cleaves fibrin, thereby causing clot dissolution and restoration of blood flow. Endothelial cells release t-PA, prostacyclin (PGI2) and nitric oxide (NO), the potent factors playing a crucial role in regulation of the fibrinolytic system. Since blood platelets can release not only prothrombotic, but also antifibrinolytic factors, like plasminogen activator inhibitor type-1 (PAI-1), they are involved in fibrynolysis regulation. Therefore agents enhancing fibrinolysis can be preferred pharmacologicals in many cardiovascular diseases. This review describes mechanisms by which major cardiovascular drugs (renin-angiotensin-aldosterone system inhibitors, statins, adrenergic receptors and calcium channel blockers, aspirin and 1-methylnicotinamide) influence fibrinolysis. The presented data indicate, that the influence of these drugs on endothelium-blood platelets interactions via NO/PGI2 pathway is fundamental for its antithrombotic and profibrinolytic action. We also described new approaches for intravital confocal real-time imaging as a tool useful to investigate mechani...Continue Reading

References

Jun 1, 1978·Pharmacological Research Communications·A SzczeklikJ Mruk
Mar 10, 1977·The New England Journal of Medicine·L A Moroz
Jan 1, 1991·Journal of Cardiovascular Pharmacology·G GleerupK Winther
Jan 1, 1986·Cephalalgia : an International Journal of Headache·K Winther, C Hedman
Oct 15, 1988·Thrombosis Research·A I Woods, M A Lazzari
Aug 1, 1987·Thrombosis Research·A I Woods, M A Lazzari
Sep 15, 1986·Biochemical Pharmacology·G de GaetanoL Mussoni
Feb 14, 1970·Lancet·I S Menon
Jul 1, 1966·The Journal of Pharmacy and Pharmacology·R Gryglewski
Sep 15, 1974·Experientia·J C Rosenior, R S Tonks
Jan 1, 1984·Seminars in Thrombosis and Hemostasis·C V Prowse, J D Cash
Jan 1, 1993·Journal of Cardiovascular Pharmacology·G M Rubanyi
Jun 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·K H Le Quan SangM A Devynck
Mar 1, 1995·American Journal of Obstetrics and Gynecology·H A BremerH C Wallenburg
Aug 30, 1994·Biochemical and Biophysical Research Communications·B PereiraL H Wang
Jun 1, 1993·Stroke; a Journal of Cerebral Circulation·H TohgiK Tamura
Dec 1, 1995·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·S WilliamsM Blombäck
Oct 9, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·L P HaleJ Owen
Apr 1, 1999·Journal of Hypertension·J I Guerra-CuestaA López-Farré
Feb 10, 2000·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·V B Schini-Kerth
Jun 3, 2000·Journal of Cardiovascular Pharmacology·M MontónA López-Farré
Nov 25, 2000·The American Journal of Cardiology·P J LevyC M Ferrario
Mar 7, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·D C Felmeden, G Y Lip
Aug 7, 2002·The Journal of Clinical Investigation·James K Liao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.